Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicergoline versus Ginkgo biloba for arterial stiffness in recent ischemic stroke or TIA
KCT0012593Phase 4Recruiting
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicergoline, ginkgo biloba extract in ischemic stroke, transient ischaemic attack (TIA), sponsored by Jeil Pharmaceutical Co., Ltd.. Started Apr 2026; status: recruiting.
02
Drugs
nicergolineginkgo biloba extract
03
Conditions
ischemic stroketransient ischaemic attack (TIA)
Beyond the preview
Go deeper on KCT0012593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012593.